2020 CRC Screening Guidelines Flashcards

1
Q

define a pt who is average risk for CRC

A

Absence of inflammatory bowel disease, family history of CRC, hereditary syndrome associated with increased risk, serrated polyposis syndrome, personal history of CRC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define normal colo

A

normal colo:

A colonoscopy where no adenoma, sessile serrated polyp, traditional serrated adenoma, hyperplastic polyp >10 mm, or CRC is found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define low risk adenoma

A

1–2 nonadvanced adenomas <10 mm in size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define advanced adenoma

A

1 or more of the following findings:

  • Adenoma >= 10 mm in size
  • Adenoma with tubulovillous/villous histology
  • Adenoma with high-grade dysplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define advanced neoplasia

A

1 or more of the following findings:

  • Adenoma >= 10 mm in size
  • Adenoma with tubulovillous/villous histology
  • Adenoma with high-grade dysplasia
  • CRC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

define high risk adenoma

A

1 or more of the following findings:

  • Advanced neoplasia
  • 3 or more adenomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

define adequate adenoma detection rate (ADR)

A

ADR >= 30% in men and >= 20% in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

define adequate bowel preparation

A

bowel preparation adequate to visualize polyps >5mm in size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define complete examination

A

Complete colonoscopy to cecum, with photo documentation of cecal landmarks, such as the appendiceal orifice, terminal ileum, or ileocecal valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define high quality examination

A

Examination complete to cecum with adequate bowel preparation performed by colonoscopist with adequate
adenoma detection rate and attention to complete polyp excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which patient population does this guideline not apply to?

A

This article does not include recommendations for follow-up for individuals with hereditary CRC syndromes (eg, Lynch syndrome and familial adenomatous polyposis), IBD, a personal history of CRC (including malignant polyps), family history of CRC or colorectal neoplasia, or serrated polyposis syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why are sessile serrated polyps and hyperplastic polyps >10 mm not included in the definition of low risk adenoma?

A

Evidence for these two types of lesions is still evolving

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are some colonoscopy quality metrics?

A

proportion of colonoscopies with adequate preparation: >85%

proportion of exams complete to cecum >95%

good documentation for polyp size:
for polyps >=10mm, include an endoscopic photo of the polyp with an open snare or open biopsy forceps next to it for comparison

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a normal colonoscopy is associated w/ what hazard ratio for reduced risk of CRC?

A

HR 0.44

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are thoughts of repeat colonoscopies for CRC detection after a normal initial colo?

A

insufficient evidence, but current recommendation is still the same: if you’ve had a normal colo, repeat in 10 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the risk of incident and fatal CRC after baseline adenoma removal?

A

uncertain (low qual ev)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the impact of surveillance colo after baseline removal of adenoma w/ high risk features (e.g. size >= 10 mm)?

A

may reduce risk for incident CRC, but impact on fatal CRC is uncertain (low qual ev)

18
Q

what is the impact of surveillance colo after baseline removal of adenoma w/ low risk features (e.g. 1-2 adenomas <10mm size)?

A

the effect of surveillance colo after baseline removal of adenoma with low risk features on the detection of incident and fatal CRC is uncertain (low qual ev)

19
Q

Recommended interval for surveillance colo for: normal colo

A

10 yrs (strong rec; high qual ev)

pts w/ normal colo have lower than average risk of CRC

20
Q

Recommended interval for surveillance colo for: pts w/ 1-2 TA’s <10mm size, completely resected

A

7-10 yrs (strong rec; mod qual ev)

previous rec was 5-10 yrs

if pt w/ this profile had the 5-10 yr rec given prior to this guideline, can keep that recommendation or adjust prn

21
Q

Recommended interval for surveillance colo for: patients w/ 3-4 TA’s <10mm, completely removed

A

repeat colo in 3-5 yrs (weak rec; very low qual ev)

22
Q

Recommended interval for surveillance colo for:

pts w/ 5-10 TA’s <10mm, completely removed

A

repeat colo at 3 yrs (strong rec; mod qual ev)

23
Q

Recommended interval for surveillance colo for:

pts w/ 1 or more adenomas >=10mm, completely removed

A

repeat colo in 3 yrs (strong rec; high qual ev)

24
Q

Recommended interval for surveillance colo for:

pts w/ adenomas containing villous histology completely removed

A

repeat colo in 3 yrs (strong rec; mod qual ev)

25
Q

Recommended interval for surveillance colo for:

pts w/ adenoma containing high-grade dysplasia completely removed

A

repeat colo in 3 yrs (strong rec; mod qual ev)

26
Q

Recommended interval for surveillance colo for:

pts w/ >10 adenomas completely resected

A

repeat colo in 1 yr (weak rec; very low qual ev)

since the last update (2012), there was only one cohort study of 214 Korean pts w />10 adenomas where 26^ had metachronous advanced adenoma.

these pts may be at increased risk of hereditary polyposis syndrome, and multiple groups have suggested that pts w/ >10 cumulative lifetime adenomas get genetic testing.

27
Q

Recommended interval for surveillance colo for:

pts w/ <=20 hyperplastic polyps <10mm in size in the rectum or sigmoid, removed

A

repeat colo in 10 yrs (strong rec; mod qual ev)

28
Q

Recommended interval for surveillance colo for:

pts w/ <=20 hyperplastic polyps <10mm in size, located proximal to sigmoid colo, removed

A

repeat colo 10 yrs (weak rec; very low qual ev)

29
Q

Recommended interval for surveillance colo for:

pts w/ 1-2 sessile serrated polyps <10mm, completely resected

A

repeat colo in 5-10 yrs (weak rec; very low qual ev)

despite the lack of good evidence, since there’s uncertainty as to impact of large serrated polyp at repeat colo, and the difficulty of complete resection of SSP’s, task force recommends 5-10 yr follow-up colo

30
Q

Recommended interval for surveillance colo for:

pts w/ traditional serrated polyp completely removed

A

repeat colo in 3 yrs (weak rec; very low qual ev)

there isn’t much new evidence since the 2012 guideline

31
Q

Recommended interval for surveillance colo for:

for pts w/ 3-4 SSP’s <10mm

A

repeat colo in 3-5 yrs (weak rec; very low qual ev)

32
Q

Recommended interval for surveillance colo for:

for pts w/ any combo of 5-10 SSPs <10mm

A

repeat colo in 3 yrs (weak rec; very low qual ev)

33
Q

Recommended interval for surveillance colo for:

pts w/ SSP >=10mm

A

repeat colo in 3 yrs (weak rec; very low qual ev)

34
Q

Recommended interval for surveillance colo for:

pts w/ hyperplastic polyp >=10mm

A

repeat colo in 3-5 yrs (weak rec; very low qual ev)

favor 3 yr f/u if there’s concern about pathologist’s consistency in distinguishing SSPs from HPs, quality of bowel prep, or complete polyp excision

35
Q

Recommended interval for surveillance colo for:

pts w/ sessile serrated polyp containing dysplasia

A

repeat colo in 3 yrs (weak rec; very low qual ev)

36
Q

Recommended interval for surveillance colo for:

pts w/ piece resection of adenoma or sessile serrated polyp >20mm

A

repeat colo in 6 mo (strong rec; mod qual ev)

piecemeal resection of polyp (vs en bloc resection) increases risk of metachronous neoplasia

it’s suggested that this is because incomplete resection is more common in piecemal resection.

Endoscopists should consider strategies for verifing complete polyp excision at baseline.

37
Q

what is the recommended surveillance scope schedule for piecemeal resection of polyps >=20mm?

A

1st surveillance: 6 mo
2nd surveillance: 1 yr from 1st surveillance.
3rd surveillance: 3 yrs from 2nd surveillance

38
Q

what are some risk factors for metachronous neoplasia?

A

MAYBE the following, but the evidence is scant:

  • smoking
  • metabolic syndrome
  • obesity
  • sedentary lifestyle
  • maybe metformin use
  • ASA, NSAIDs may reduce risk of adenoma recurrence

though there is evidence that black pts have higher age-adjusted incidence and mortality from CRC, and develop CRC at younger age than other ethnic/racial groups, once screened, there is no robust evidence that black race modifies the risk for recurrent adenoma or advanced neoplasia

39
Q

what is hte USPSTF’s stance on low dose aspirin for CRC primary prevention?

A

for pts age 50-59y w/ >=10% risk of CVD and life expectancy >=10 yrs w/o increased risk of bleeding, ASA 81mg once daily is recommended for primary prevention of both CVD and CRC (grade B rec)

may also consider for pts 60-69y/o based on shared decision making (Grade C rec)

40
Q

summary of key updates since the 2012 recommendations

A
  • New evidence based on risk of colorectal cancer outcomes, rather than based only on risk of advanced adenoma during surveillance, is provided to strengthen polyp surveillance recommendations
  • 7- to 10-y rather than 5- to 10-y follow-up is recommended after removal of 1–2 tubular adenomas <10 mm in size (Table 4)
  • More detailed recommendations for follow-up after removal of serrated polyps have been provided (Table 5)
  • Importance of high-quality baseline examination has been emphasized
  • 1 y rather than <3-y follow-up is recommended after removal of >10 adenomas
  • Option to recommend 3–5 y instead of 3-y follow-up after removal of 3–4 adenomas <10 mm in size